Canaccord can show our calculations to deep-pocket investors Anyone thinking should have sold in the 40s probably get another chance soon. 2 more trading days before QuestCap become Medivolve Inc. It does seem everything is lining up with January 7, 2020. They could have waited to announce this on Friday after the market closed If this was such a bad deal.
I don't think they will give out 20 million shares at .25 to Canaccord at the last stage before becoming profitable. There must be an agreement to buy the shares from the open market or required stock performance.
Canaccord knows all kinds of investors and if they take these numbers. Those we calculate every day, how many testing sites, how many tests per day, per site and revenue per test. I am sure many of those investors will be buying at prices. If Canaccord wanted to keep buying or selling at these prices, they could do that in the open market. Like a few weeks back, QSC was trading .15 to .25 cents. Why did they need to get into private placement?
In a few weeks, Medivolve should have 100 testing sites up and running. Those testing sites can generate $30 million-plus per month. So no way Medivolve will keep trading at .25-.35 cents.
Yes, 20 million extra issued shares do make a difference, but if Canaccord can help to bring more investors buying Medivlve. It should be all worthwhile.